Why study Pharmaceutical and Biopharmaceutical Engineering?
The enormous need for Engineers to work in the pharmaceutical, biopharmaceutical and medical devices industries has been well documented in recent years, most recently by the Expert Group on Future Skills Needs (EGFSN). The 2024 report suggests the possibility of creation of over 6000 jobs in this sector by 2027, primarily driven by jobs in manufacturing, followed by jobs in the services sector. This will require significant upskilling of the existing workforce in the Pharma/Biopharma sectors, and development of industry-academia collaborations fostering re-skilling.
Many graduates working in the pharmaceutical industries with a scientific background find themselves working in areas which increasingly overlap with engineers and engineering. Many would like to develop an engineering-based understanding of processes and production in a formal manner. This course offers you the opportunity to do this, developing your skill set and employability across a wider range of roles.
The course also presents the pharmaceutical and biopharmaceutical industry with an opportunity to enable greater cohesion and understanding among inter- and multi-disciplinary teams as graduates with science backgrounds receive a formal qualification in engineering.
Who should apply?
The aim of this (NFQ level 9) programme is to provide upskilling/re-skilling opportunities for working professionals in the Engineering and Manufacturing sectors. It is also aimed to fill the need for the Continuing Professional Development (CPD) and Postgraduate Education of Engineers working in the Pharmaceutical Industry.
To date many Engineering graduates (including Chemical & Process Engineering graduates) do not have formal educational qualifications relating specifically to the pharmaceutical industry. This is because many undergraduate Chemical Engineering courses, which are generally broad in nature, do not cover issues of particular concern to the pharmaceutical industry; issues such as product containment, powder/particle technology, design of API and secondary production facilities, current Good Manufacturing Practice (cGMP), design of classified facilities, aseptic processing facility design, validation, etc. This is the case to an even greater extent the case for graduates of other Engineering disciplines.
Parallelly, many graduates working in the pharmaceutical industries with a scientific background find themselves working in areas which increasingly overlap with engineers and engineering. Many of them would like to develop an engineering-based understanding of processes and production in a formal manner. This programme offers these graduates with significant benefits both to themselves and their companies by developing their skill set and employability across a wider range of roles through the enhanced continuing professional development that this programme offers. This programme also offers the pharmaceutical and biopharmaceutical industry with an opportunity to enable greater cohesion and understanding among inter and multi-disciplinary teams as graduates with science backgrounds, but relevant experience in Engineering, receive a formal Level 9 qualification in engineering.
Who teaches this course?
This course provides a unique opportunity to learn from academics and industry professionals alike. Modules are delivered by academics from the Discipline of Process and Chemical Engineering, School of Engineering and Architecture and the School of Chemistry. A number of modules are delivered by lecturers from leading industries including Eli Lilly, Janssen, MSD and PM Group. The course also features a module on Biopharmaceutical Engineering delivered by the National Institute for Bioprocessing Research and Training (NIBRT), Dublin, designed to provide hands-on-training and insight into state-of-the-art biopharmaceutical manufacturing processes and practises.
What are the key learning outcomes?
Upon completion of this programme, candidates will be able to:
